Viewing nowSelpireed Tablets (Glymepiride)
Glimepiride 2mg
Tablet · Prescription medication
Telcon RF Pharmaceutical Co., Ltd.

MFDS item code 201501001 · Approved 2015.02.25 · Insurance code 625500280
Improvement of glycemic control in patients with type 2 diabetes
This medication is an adjunct to dietary and exercise therapy to help improve blood sugar control in patients with type 2 diabetes. It can also be used alone, but if blood sugar control is inadequate, it may be administered in combination with insulin or other oral hypoglycemic agents. Especially in cases where blood sugar control is difficult with monotherapy using sulfonylureas or metformin, it can be used alongside metformin for more effective blood glucose management. This medication improves blood sugar control in patients with type 2 diabetes.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under the initial dose. That is, start at 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management when sulfonylurea medicines are administered. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may be increased. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes mellitus or in patients with diabetic ketoacidosis or coma. Additionally, patients with allergies to this medication, its components, sulfonylureas, or sulfonamide drugs should not be administered this drug. The safety has not been established in patients with severe impairment of liver or kidney function, and it is recommended to switch to insulin treatment in these cases. This medication should also not be used in pregnant women or breastfeeding mothers. In patients with severe infections or pre/post-surgical conditions, insulin therapy is recommended, and patients with gastrointestinal disturbances such as diarrhea or vomiting may have unstable absorption of the drug, increasing the risk of hypoglycemia. Also, since this medication contains lactose, it should not be administered to patients with genetic disorders affecting lactose metabolism. During the first week of treatment, there is an increased risk of hypoglycemia, so careful monitoring of blood sugar is necessary. Careful management is particularly needed for elderly patients, those with poor nutritional status or irregular eating habits, those whose physical activity and carbohydrate intake do not align, those who have changed eating patterns, and those who consume alcohol. Patients with reduced kidney or liver function, those who have overdosed on other medications, and those with thyroid or adrenal dysfunction also have an increased risk of hypoglycemia, requiring caution. In case of hypoglycemic symptoms, contact a doctor or pharmacist immediately, and dosage adjustments or changes in administration method may be necessary. This medication can cause hypoglycemia due to its blood sugar-lowering effect, with symptoms such as headache, severe hunger, nausea, vomiting, fatigue, anxiety, confusion, drowsiness, and decreased consciousness. Severe hypoglycemia can lead to coma, so if symptoms occur, immediate intake of sugar or seeking medical assistance is essential. Additionally, temporary blurring of vision or gastrointestinal symptoms may occur at the start of treatment due to changes in blood sugar. Rarely, liver dysfunction, changes in blood cell counts, or allergic reactions may occur, and any abnormal symptoms should be discussed with healthcare professionals immediately. When taking this medication, regular meals, exercise, and weight management should be maintained, and it is essential to consume sugar promptly in case of hypoglycemia. Artificial sweeteners are not effective in controlling hypoglycemia, so sugar intake is necessary. It is important to inform healthcare professionals of any changes in treatment or lifestyle patterns, as stress situations can complicate blood sugar control, potentially leading to a switch to insulin treatment. This medication can interact with several drugs, so consulting with healthcare providers is crucial if taking other medications. Caution is especially needed when used with drugs that raise or lower blood sugar. Some medications, such as beta-blockers, may mask the symptoms of hypoglycemia. Pregnant or breastfeeding women should avoid using this medication as it may harm the fetus or newborn; it is safer to switch to insulin treatment if necessary. The safety and efficacy in children have not been sufficiently established, so it is recommended not to use it in children under 18 years of age. For the elderly, since kidney function may be impaired, they should be administered the drug cautiously with dosage adjustments. In the case of overdose, hypoglycemia can be very dangerous, necessitating immediate emergency treatment at a medical institution, which may include inducing vomiting, blocking drug absorption, or administering glucose injections. This medication should be stored out of reach of children and kept in its original container for safety.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, venous arrhythmias, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased hepatic enzymes, hepatic dysfunction, biliary secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, hepatic dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly closed container to protect it from air and moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius to preserve the medication's effectiveness.
Green rectangular tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Telcon RF Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.